Abstract: Compounds of formula I:
wherein R1 and R2 have any of the values defined in the specification, and their pharmaceutically acceptable salts, are PKC activators and are useful for treating diseases, such as, for example, cancer. Also disclosed are pharmaceutical compositions comprising compounds of formula I, processes for preparing compounds of formula I, and intermediates useful for preparing compounds of formula I.
Type:
Grant
Filed:
June 23, 1999
Date of Patent:
September 4, 2001
Assignee:
Georgetown University
Inventors:
Alan P. Kozikowski, Shaomeng Wang, Lixin Qiao